We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Swiss CDMO may be struggling in some areas, but it is continuing an expansion binge for its pharma manufacturing as it leans more heavily on it to drive its growth.